Clinical Trial Update: The Use of CT Perfusion to Determine the Normalization Window Period in the Treatment of Advanced Primary Lung Adenocarcinoma With Endostar [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring using CT perfusion imaging to determine the normalization window during treatment of advanced non-small cell lung cancer with E…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Simcere Pharmaceutical Co., Ltd | Conditions: Advanced Primary Lung Adenocarcinoma | Phase 2 | Status: UNKNOWN